Jin Medical International Ltd. (ZJYL)

NASDAQ: ZJYL · Real-Time Price · USD

2.020

-0.060 (-2.88%)

At close: Sep 8, 2026, 4:00 PM EDT

2.300

+0.220 (10.58%)

Pre-market: Sep 9, 2026, 5:31 AM EDT

Jin Medical International Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	19.73	20.69	23.5	19.82	19.19	20.76
Revenue Growth	-13.59%	-11.98%	18.57%	3.29%	-7.58%	28.22%
Cost of Revenue	13.55	14.44	13.89	12.86	12.83	14.18
Gross Profit	6.17	6.24	9.61	6.96	6.36	6.59
Selling, General & Admin	3.84	3.88	4.37	2.37	2.18	2.16
Research & Development	1.78	1.56	1.5	1.54	1.89	1.57
Other Operating Expenses	0.13	0.2	0.11	0.18	0.16	0.23
Operating Expenses	5.75	5.63	5.97	4.1	4.23	3.95
Operating Income	0.42	0.61	3.64	2.87	2.13	2.63
Interest Expense	-	-	-	-	-	-0.01
Interest & Investment Income	0.53	0.79	0.47	0.18	0.18	-
Currency Exchange Gain (Loss)	-0.28	0.02	-0.03	-0.05	0.19	0.06
Other Non Operating Income (Expenses)	0.6	0.18	0.11	0.22	0.24	0.19
Pretax Income	1.26	1.6	4.18	3.22	2.74	2.88
Income Tax Expense	0.1	0.21	0.76	0.34	0.04	0.25
Earnings From Continuing Operations	1.16	1.38	3.42	2.88	2.71	2.63
Minority Interest in Earnings	0.01	-0.19	0.26	-	-	-
Net Income	1.17	1.19	3.68	2.88	2.71	2.63
Net Income to Common	1.17	1.19	3.68	2.88	2.71	2.63
Net Income Growth	-34.60%	-67.59%	27.71%	6.34%	2.84%	19.30%
Shares Outstanding (Basic)	8	8	8	7	7	7
Shares Outstanding (Diluted)	8	8	8	7	7	7
Shares Change	-	0.05%	7.81%	7.51%	-	-66.25%
EPS (Basic)	0.15	0.15	0.47	0.40	0.40	0.39
EPS (Diluted)	0.15	0.15	0.47	0.40	0.40	0.39
EPS Growth	-34.60%	-67.61%	18.46%	-1.08%	2.84%	253.48%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Free Cash Flow	-6.96	-3.73	-1.35	2.99	1.54	5.8
Free Cash Flow Per Share	-0.89	-0.48	-0.17	0.41	0.23	0.86
Gross Margin	31.28%	30.18%	40.89%	35.14%	33.13%	31.72%
Operating Margin	2.12%	2.94%	15.48%	14.46%	11.10%	12.67%
Profit Margin	5.95%	5.76%	15.64%	14.52%	14.10%	12.67%
Free Cash Flow Margin	-35.28%	-18.01%	-5.75%	15.10%	8.03%	27.93%
EBITDA	0.66	0.85	3.88	3.09	2.49	2.98
EBITDA Margin	3.33%	4.12%	16.50%	15.60%	12.99%	14.34%
D&A For EBITDA	0.24	0.24	0.24	0.23	0.36	0.35
EBIT	0.42	0.61	3.64	2.87	2.13	2.63
EBIT Margin	2.12%	2.94%	15.48%	14.46%	11.10%	12.67%
Effective Tax Rate	7.84%	13.45%	18.26%	10.67%	1.32%	8.63%
Revenue as Reported	19.73	20.69	23.5	19.82	19.19	20.76

SEC Filings: 10-K · 10-Q